fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Soda ingredient poses cancer risk

Written by | 2 Mar 2015

Public health researchers have analyzed soda consumption data in order to characterize people’s exposure to a potentially carcinogenic byproduct of some types of caramel color.

Bisphosphonates with nitrogen appear to lower risk of endometrial cancer

Written by | 20 Jan 2015

by Bruce Sylvester: Women using bisphosphonates with nitrogen, which are prescribed for osteoporosis and other bone conditions, appear to have half the risk of developing endometrial cancer compared… read more.

Team finds drug repurposing signal in e-health records

Written by | 3 Dec 2014

With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have… read more.

ESMO 2014 Report: Reclassifying cancer through genomics

Written by | 19 Nov 2014

Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley.  On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.

ESMO 2014: Poster Session: REBECCA

Written by | 12 Nov 2014

by Denys Wheatley: A large cohort study of Regorafenib (REG) in the real-life setting in patients previously treated for metastatic colorectal cancer

ESMO 2014 Report: Precision medicine: Panacea or false dawn?

Written by | 6 Nov 2014

Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley:  In his talk on Visualising the true spectrum of cancer- will we get… read more.

Obesity, large waist size risk factors for COPD

Written by | 22 Aug 2014

Obesity, especially excessive belly fat, is a risk factor for chronic obstructive pulmonary disease (COPD), according to an article in CMAJ (Canadian Medical Association Journal) Excessive belly fat… read more.

Joint International Congress of ILTS, ELITA and LICAGE 2014: Making the most of a new liver

Written by | 4 Aug 2014

by Professor John O’Grady, Kings College Hospital, London – Liver transplantation is highly successful from the technical perspective, returning the majority of patients to a level of health… read more.

Lenvatinib Phase III results show significant improvement in progression-free survival in people with Radioiodine-Refractory differentiated Thyroid Cancer

Written by | 26 Jun 2014

Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO) – Press Release.

Cbl-b, a target for drugs used to treat allergic asthma

Written by | 7 May 2014

Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response.  An enzyme that helps maintain immune system function by “throwing away” a specific… read more.

ACC 2014 Report: Underweight same high risk of dying as obese people

Written by | 29 Apr 2014

The connection between being underweight and the higher risk of dying is true for both adults and foetuses.  Being underweight puts people at highest risk of dying, just… read more.

Novel agent shows promise for non-small cell lung cancer

Written by | 3 Dec 2013

by Bruce Sylvester – Researchers report that an experimental cancer drug which has shown efficacy in  treating melanoma also shows promise  in treating non-small cell lung cancer, a… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.